243 - Why Kitting A Finished Medical Device with a Drug Create So Much Work

Let's Combinate · 24 Jun 2026 · 14m

What this episode covers

Subhi Saadeh, Founder of Let’s Combinate, explains why selecting commercially available finished medical devices for combination product kits creates significant regulatory and quality challenges. He argues that an 'already approved' device is not automatically qualified for a new combination product context, as the buyer inherits the supplier's design, QMS, and validation decisions. Saadeh outlines three critical lifecycle moments—before, during, and after supplier selection—to mitigate risks, emphasizing the need for structured qualification using PPAP concepts like PFMEA and control plans. He warns that assuming commercial availability equals suitability often leads to late-stage failures, such as coring issues or market approval gaps.

Other shows on the same ground, closest first.

  • Global Medical Device Podcast · 35m

    #467: Combination Product Compliance: PMOA, 21 CFR Part 4 & QMS Alignment

    Jim Fentress, Director of Regulatory Affairs at Galero (a Santa Group company), explains the regulatory complexities of combination products, focusing on how the Primary Mode of Action (PMOA) dictates FDA oversight. He details the challenges pharmaceutical companies face when integrating device Quality Management Systems (QMSR/ISO 13485) into their existing CGMP frameworks under 21 CFR Part 4. The discussion covers specific friction points like risk management alignment (AAMI TIR105 vs. ICH Q9), labeling classifications, and the critical need for transparent change control protocols between device manufacturers and pharma partners.

  • Global Medical Device Podcast · 38m

    #380: Navigating the Complex World of Combination Products with Subhi Saadeh

    Subhi Saadeh, host of the Combinate Podcast and expert in combination products, discusses the regulatory complexities of integrating drugs, devices, and biologics, including the differences between US FDA and EU regulatory pathways. He explains the definitions of single entity, co-packaged, and cross-labeled products, and addresses common misconceptions about the differences between drug and device quality systems. Saadeh also shares his journey of starting the podcast to maintain consistent learning and production, highlighting the importance of lifelong learning and leveraging coaching to balance technical and business aspects of the MedTech industry.

  • Global Medical Device Podcast · 39m

    Why Supplier Quality Management Is So Important For Medical Device Companies

    Mike Drues of Vascular Sciences joins host John Spear to discuss supplier quality management, emphasizing that medical device companies retain ultimate responsibility for third-party services even when work is delegated. They use Ethylene Oxide (EtO) sterilization as a case study for supplier failure, noting that relying solely on EtO vendors creates a single point of failure when capacity is constrained by environmental regulations. Drues advocates for a risk-based approach to supplier criticality, suggesting multiple levels of assessment rather than a binary critical/non-critical classification, and highlights the business necessity of creating win-win partnerships with backup suppliers to ensure supply chain resilience.

  • Global Medical Device Podcast · 31m

    Knowing vs. Doing as Medical Device Professionals

    John Kapitan, CEO of Kapstone Medical, joins host John Speer to discuss the gap between knowing and doing in medical device quality systems. Kapitan categorizes professionals into three buckets: the ignorant, the antagonistic, and the apathetic, arguing that quality is a mindset rather than just a compliance burden. He warns that pre-revenue startups often neglect quality documentation, which can severely damage valuation during M&A due diligence by strategic acquirers. Kapitan advocates for a pragmatic, modular approach to building quality systems, cautioning against over-engineering processes for small companies.

  • Global Medical Device Podcast · 42m

    How to Select a Contract Manufacturer

    Mark Rutkiewicz, VP of Quality at Innovize and founder of Consiliso LLC, explains how medical device companies should select and manage contract manufacturers (CMs). He emphasizes the importance of supplier quality agreements, risk-based criticality levels, and the use of MedAccred for auditing. The discussion covers the trade-offs between manual and automated processes, the necessity of master validation plans, and the need for transparent communication regarding patient impact and product usage.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Let's Combinate. The episode itself belongs to its publisher.